Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
adequacy, age, analogy, antiviral, Australian, booster, circulation, cleavage, CMO, convalescent, COSO, CRO, Delta, deteriorate, disposition, durability, enabling, endemic, escape, exploratory, feedback, float, grated, haul, honor, hourly, HREC, Hunan, IAS, IEC, Inline, interact, Interactive, invoice, invoiced, Kingdom, medium, menopause, NaN, necessitated, negotiate, negotiation, neoadjuvant, obsolete, Omicron, outreach, outset, overestimate, pattern, PIND, plasma, prepayment, reclassification, release, shipping, Swedish, thereon, timeline, transmissible, trend, UK, unclear, underestimate, uneven, unknown, unqualified, unregistered, vaccinated, vaccine, wholly
Removed:
achieved, Acueity, Affordability, Affordable, aggressive, aid, altogether, attempting, biopsy, cancellation, ceased, certainty, CFO, China, choice, commercialized, conditioned, confirmatory, conflict, constituent, contamination, creation, cycle, decide, declare, denying, determination, diligence, dilute, discontinue, disinterested, diverted, Education, effecting, eliminate, excessive, expressing, forecyte, fullcyte, harmful, Head, improvement, inconsistency, inform, inside, installation, instituted, intensive, intermediate, justify, knowledge, labor, marketplace, offset, operator, penny, perspective, pharmacy, predicted, promulgated, prospectively, Reconciliation, recurrent, refocused, remeasured, resolved, Rule, scale, scheduled, spend, stemming, strain, strictly, suggest, threatened, unanimously, variability, variety, visible, Wall, window, withdraw, woman
Filing tables
Filing exhibits
Related press release
ATOS similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Atossa Therapeutics, Inc.
Seattle, Washington
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (No. 333-250820 and 333-223949), Form S-3 (No. 333-255411, 333-254548, 333-252335, 333-248555, 333-192390 and 333-220572), and Form S-8 (No. 333-254905, 333-185625 and 333-193952) of Atossa Therapeutics, Inc. of our reports dated February 28, 2022, relating to the consolidated financial statements and the effectiveness of Atossa Therapeutics, Inc.’s internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO USA, LLP |
|
|
|
Seattle, Washington |
|
February 28, 2022 |
|